NCT05594719

Brief Summary

In 2020, the overall myopia rate among children and adolescents was 52.7% in China. The COVID-19 pandemic has increased students' time of indoor eye-using, and it showed that the light exposure intensity of myopic students is lower than that of non-myopia students. Studies have found that in addition to exposure to light intensity, the occurrence and development of myopia is also related to the color temperature and wavelength band of light. The sun-like spectrum refers to the spectrum with continuous wavelength bands. Animal experiments suggest that sun-like artificial lighting can prevent myopia, but the relationship between sun-like artificial lighting with different color temperatures and myopia is unknown. Clinical trials suggest that artificial lighting with a sun-like spectrum can delay fundus blood flow decline. One hypothesis is that reduced choroidal blood flow leads to scleral hypoxia and promotes the development of myopia. This study aims at comparing the effects of sun-like spectrum artificial lighting with different dominant wavelengths on the human eye, and providing clues for the prevention and control of myopia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 6, 2022

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

October 1, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

October 26, 2022

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2022

Completed
Last Updated

October 26, 2022

Status Verified

October 1, 2022

Enrollment Period

2 months

First QC Date

October 1, 2022

Last Update Submit

October 25, 2022

Conditions

Keywords

myopiaretinal blood flowaccommodative micro-fluctuationartificial lighting

Outcome Measures

Primary Outcomes (1)

  • Retinal blood flow density after reading

    Data werevcollected from Optovue AngioVue OCT (macular blood data collected), dominant eye examined

    At the timepoint after reading for 1 hour

Secondary Outcomes (1)

  • Accommodation ability after reading

    At the timepoint after reading for 1 hour

Study Arms (3)

Light group 1

EXPERIMENTAL

Sun-like spectrum, color temperature of 5000K, shorter-wavelength dominant;

Device: Shorter-wavelength dominant light

Light group 2

PLACEBO COMPARATOR

Sun-like spectrum, color temperature of 5000K, wavelength proportion similar to the sunlight

Device: Light similar to the solar spectrum proportion

Light group 3

EXPERIMENTAL

Sun-like spectrum, color temperature of 5000K, longer-wavelength dominant.

Device: Shorter-wavelength dominant lightDevice: Longer-wavelength dominant light

Interventions

Shorter-wavelength dominant light

Light group 1Light group 3

Light similar to the solar spectrum proportion with no specific wavelength dominant

Light group 2

Longer-wavelength dominant light

Light group 3

Eligibility Criteria

Age7 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • School students aged from 7 to 15, regardless of sex or gender;
  • Diopter between -2.0D and 3.0D, and astigmatism not exceed 0.75D;
  • No organic disease and in good general condition;
  • Have obtained the consent of their parents or guardians, and can cooperate.

You may not qualify if:

  • Suffering from amblyopia, strabismus, color weakness, congenital cataract, glaucoma and other eye diseases;
  • Other circumstances judged by the investigator to be unsuitable to participate in the research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Xiangui He

Shanghai, Shanghai Municipality, 200040, China

RECRUITING

Shanghai Eye Disease Prevention and Treatment Center

Shanghai, Shanghai Municipality, 200041, China

RECRUITING

Related Publications (6)

  • Mirhajianmoghadam H, Pina A, Ostrin LA. Objective and Subjective Behavioral Measures in Myopic and Non-Myopic Children During the COVID-19 Pandemic. Transl Vis Sci Technol. 2021 Sep 1;10(11):4. doi: 10.1167/tvst.10.11.4.

    PMID: 34473223BACKGROUND
  • Muralidharan AR, Lanca C, Biswas S, Barathi VA, Wan Yu Shermaine L, Seang-Mei S, Milea D, Najjar RP. Light and myopia: from epidemiological studies to neurobiological mechanisms. Ther Adv Ophthalmol. 2021 Dec 19;13:25158414211059246. doi: 10.1177/25158414211059246. eCollection 2021 Jan-Dec.

    PMID: 34988370BACKGROUND
  • Rucker F. Monochromatic and white light and the regulation of eye growth. Exp Eye Res. 2019 Jul;184:172-182. doi: 10.1016/j.exer.2019.04.020. Epub 2019 Apr 21.

    PMID: 31018118BACKGROUND
  • Baeza Moyano D, González-Lezcano RA. Pandemic of Childhood Myopia. Could New Indoor LED Lighting Be Part of the Solution? Energies. 2021;14(13):3827. doi:10.3390/en14133827

    BACKGROUND
  • 陈军, 陈友三, 王菁菁, et al. 类太阳光谱LED照明对儿童青少年视网膜血流灌注影响的随机对照临床试验. zgxxws. 2022;43(3):338-340. doi:10.16835/j.cnki.1000-9817.2022.03.005

    BACKGROUND
  • Liu Y, Wang L, Xu Y, Pang Z, Mu G. The influence of the choroid on the onset and development of myopia: from perspectives of choroidal thickness and blood flow. Acta Ophthalmol. 2021 Nov;99(7):730-738. doi: 10.1111/aos.14773. Epub 2021 Feb 7.

    PMID: 33550704BACKGROUND

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Officials

  • Xiangui He, PhD

    Shanghai Eye Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Xiangui He, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participants were randomly divided into three groups without knowing the type of light
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The participants were randomly divided into the following three groups: 1. Sun-like spectrum, color temperature of 5000K, shorter-wavelength dominant; 2. Sun-like spectrum, color temperature of 5000K, wavelength proportion similar to the sunlight; 3. Sun-like spectrum, color temperature of 5000K, longer-wavelength dominant.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2022

First Posted

October 26, 2022

Study Start

September 6, 2022

Primary Completion

October 30, 2022

Study Completion

October 30, 2022

Last Updated

October 26, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations